Kim Boggess

Based at Cornell University, Kim Boggess focuses their scholarly efforts on preeclampsia, gestational diabetes, preterm birth, chorioamnionitis, perinatal outcomes, maternal-fetal medicine, pregnancy complications, social determinants of health, bridging the gap between theory and practice in preeclampsia. A representative example of their recent contribution is the study titled "Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Early Pregnancy", which offers critical insights into the dynamics of preeclampsia and gestational diabetes. Additional work such as "Plasma soluble fms-like tyrosine kinase 1 to placental growth factor ratio of 11.5 multiples of median predicts preeclampsia with severe features within 2 weeks of testing" further demonstrates their commitment to advancing knowledge in this domain.